Literature DB >> 2104224

Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells.

M Turner1, D Chantry, M Feldmann.   

Abstract

Previous studies have indicated that the cytokine transforming growth factor beta 1 (TGF beta 1) has immunosuppressive properties and can inhibit the production of tumor necrosis factor (TNF) and Interleukin 1 (IL 1) by human peripheral blood mononuclear cells. In this study, we have examined the effects of TGF beta 1 on the production of Interleukin 6 (IL 6) by human peripheral blood mononuclear cells. Treatment with only TGF beta 1 leads to the induction of IL 6, and this was both dose- and time-dependent. The effect of TGF beta 1 was evident at the level of IL 6 mRNA, suggesting TGF beta 1-induced de novo synthesis of IL 6. Induction of IL 6 by TGF beta 1 was specific, as other cytokines made by mononuclear cells (TNF and IL 1) were not induced by TGF beta 1. Furthermore, when a panel of stimuli were compared for their ability to induce IL 1, TNF and IL 6 in the presence or absence of TGF beta 1, IL 6 levels were augmented in the presence of TGF beta 1, while the induction of IL 1 and TNF was inhibited significantly. These results indicate that TGF beta 1 has complex effects on the production of cytokines by peripheral blood mononuclear cells and that TGF beta 1 is not inhibitory for all cytokine production. The ability of TGF beta 1 to induce IL 6 suggests that IL 6 may mediate some of the effects of TGF beta 1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104224     DOI: 10.1016/1043-4666(90)90018-o

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  24 in total

1.  The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines.

Authors:  N L Brown; S A Alvi; M G Elder; P R Bennett; M H Sullivan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

3.  Age-associated alteration in innate immune response in captive baboons.

Authors:  Dianne McFarlane; Roman F Wolf; Kristen A McDaniel; Gary L White
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-22       Impact factor: 6.053

Review 4.  Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

Authors:  Shomyseh Sanjabi; Soyoung A Oh; Ming O Li
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

5.  Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.

Authors:  I M Goulart; J R Mineo; N T Foss
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

6.  Induction of IL-6 expression by mechanical stress in the trabecular meshwork.

Authors:  Paloma B Liton; Coralia Luna; Marc Bodman; Anna Hong; David L Epstein; Pedro Gonzalez
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

7.  Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs.

Authors:  Shannon Sedberry Allen; Lynne Cassone; Todd M Lasco; David N McMurray
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 8.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

9.  Transforming growth factor-beta enhances interleukin-6 secretion by intestinal epithelial cells.

Authors:  D W McGee; K W Beagley; W K Aicher; J R McGhee
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 10.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.